GILLIAN EDWARDS: Open Payments
NPI 1609544337 · OGDENSBURG, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$761 in 23 payments from 14 companies in 2025. Trend: 2023 $89 · 2024 $422 · 2025 $761
Food & beverage: $464Education: $297
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $130 |
| Incyte Corporation | 2 | $117 |
| SEAGEN INC. | 1 | $99 |
| Daiichi Sankyo Inc. | 3 | $84 |
| Regeneron Healthcare Solutions, Inc. | 3 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $66 |
| Merck Sharp & Dohme LLC | 2 | $50 |
| Astellas Pharma US Inc | 1 | $35 |
| Karyopharm Therapeutics Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $21 |
Products named: DARZALEX, LIBTAYO, Enhertu, KEYTRUDA, Xtandi, RYBREVANT, DATROWAY, IMFINZI.
Industry payments across NY — which companies pay providers there.
